22% of revenue for Life Sciences cos to come from connected health
image for illustrative purpose
![22% of revenue for Life Sciences cos to come from connected health 22% of revenue for Life Sciences cos to come from connected health](https://www.bizzbuzz.news/h-upload/2024/06/19/1916818-life-sciences.webp)
New Delhi: As the majority (63 per cent) of Life Sciences organisations, across biopharma and medtech, have connected health products already on the market or under development, the industry anticipates that connected health will contribute more than one-fifth of their total revenue (22 per cent) in the next five years, a new report showed on Tuesday.
According to the IT firm Capgemini, three in five Life Sciences organisations are currently developing a roadmap for integrating Generative AI, and over half are already piloting genAI for interactions with patients and healthcare providers (HCPs).
"Unlocking the power of healthcare data and leveraging the possibilities posed by breakthrough technologies, such as Generative AI, will be at the heart of this connected health revolution," said Thorsten Rall, Global Life Sciences Industry Leader at Capgemini.
"They can accelerate drug development, enhance patient care, and have the potential to reshape what 'product' actually means for pharmaceuticals, especially medtech companies," he added.
The report surveyed 420 industry executives from various biotechnology, pharmaceutical (biopharma), and medtech organisations exploring connected health initiatives with annual revenues exceeding $500 million.
The report also found that there has been a six-fold increase in biopharma organisations with market-ready connected products since 2021.